An Updated Comparison of Drug Dosing Methods
暂无分享,去创建一个
K. Rodvold | R D Pryka | K A Rodvold | S M Erdman | S. Erdman | R. Pryka
[1] J. Rotschafer,et al. Evaluation of a Two‐Compartment Bayesian Forecasting Program for Predicting Vancomycin Concentrations , 1989, Therapeutic drug monitoring.
[2] G. Mccracken,et al. Clinical pharmacology and efficacy of vancomycin in pediatric patients. , 1980, The Journal of pediatrics.
[3] W. Keane,et al. Pharmacokinetics of vancomycin in patients with various degrees of renal function , 1984, Antimicrobial Agents and Chemotherapy.
[4] R. Slaughter,et al. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. , 1987, The American journal of medicine.
[5] D. T. Rock,et al. Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers , 1987, Antimicrobial Agents and Chemotherapy.
[6] J. Sheagren. Staphylococcus aureus: The Persistent Pathogen , 1984 .
[7] T. Sorrell,et al. A prospective study of adverse reactions associated with vancomycin therapy. , 1985, The Journal of antimicrobial chemotherapy.
[8] D. T. Rock,et al. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. , 1988, The Journal of infectious diseases.
[9] P. Elmes,et al. Vancomycin: Report on Treatment of Patients with Severe Staphylococcal Infections , 1959, British medical journal.
[10] G. Koren,et al. Vancomycin pharmacokinetics and dose recommendations for preterm infants , 1987, Antimicrobial Agents and Chemotherapy.
[11] J. Rotschafer,et al. Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations , 1982, Antimicrobial Agents and Chemotherapy.
[12] M. Rybak,et al. Vancomycin pharmacokinetics in burn patients and intravenous drug abusers , 1990, Antimicrobial Agents and Chemotherapy.
[13] R. Brummett,et al. Vancomycin- and erythromycin-induced hearing loss in humans , 1989, Antimicrobial Agents and Chemotherapy.
[14] M. Chandler,et al. Short Communication; Using Clinical Data to Determine Vancomycin Dosing Parameters , 1990, Therapeutic drug monitoring.
[15] D. Brater,et al. Bayesian and Least‐Squares Methods for Vancomycin Dosing , 1987, The American journal of the medical sciences.
[16] R. Kliegman,et al. The Clinical Pharmacology of Vancomycin in Seriously Ill Preterm Infants , 1987, Pediatric Research.
[17] R. Polin,et al. Vancomycin pharmacokinetics in infants: relationships to indices of maturation. , 1986, Pediatric infectious disease.
[18] R W Jelliffe,et al. Application of a Bayesian method to monitor and adjust vancomycin dosage regimens , 1990, Antimicrobial Agents and Chemotherapy.
[19] J. Rotschafer,et al. Vancomycin pharmacokinetics in patients with various degrees of renal function , 1988, Antimicrobial Agents and Chemotherapy.
[20] M. Rybak,et al. Nephrotoxicity of vancomycin, alone and with an aminoglycoside. , 1990, The Journal of antimicrobial chemotherapy.
[21] M. Vasko,et al. Comparison of Drug Dosing Methods , 1985, Clinical pharmacokinetics.
[22] B. Farber,et al. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 , 1983, Antimicrobial Agents and Chemotherapy.
[23] R. Blouin,et al. Vancomycin pharmacokinetics in normal and morbidly obese subjects , 1982, Antimicrobial Agents and Chemotherapy.
[24] G. Matzke,et al. Clinical Pharmacokinetics of Vancomycin , 1986, Clinical pharmacokinetics.
[25] D. Louria,et al. Vancomycin in severe staphylococcal infections. , 1961, Archives of internal medicine.
[26] R. Polk,et al. Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions , 1990, Antimicrobial Agents and Chemotherapy.